BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24969275)

  • 61. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
    Spinelli A; Bonovas S; Burisch J; Kucharzik T; Adamina M; Annese V; Bachmann O; Bettenworth D; Chaparro M; Czuber-Dochan W; Eder P; Ellul P; Fidalgo C; Fiorino G; Gionchetti P; Gisbert JP; Gordon H; Hedin C; Holubar S; Iacucci M; Karmiris K; Katsanos K; Kopylov U; Lakatos PL; Lytras T; Lyutakov I; Noor N; Pellino G; Piovani D; Savarino E; Selvaggi F; Verstockt B; Doherty G; Raine T; Panis Y
    J Crohns Colitis; 2022 Feb; 16(2):179-189. PubMed ID: 34635910
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Standardized recording of parameters related to the natural history of inflammatory bowel disease: from Montreal to Paris.
    Hyams JS
    Dig Dis; 2014; 32(4):337-44. PubMed ID: 24969277
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Medical and surgical therapy of inflammatory bowel disease in the elderly - prospects and complications.
    Stallmach A; Hagel S; Gharbi A; Settmacher U; Hartmann M; Schmidt C; Bruns T
    J Crohns Colitis; 2011 Jun; 5(3):177-88. PubMed ID: 21575879
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complications and adverse effects related to surgical and medical treatment in patients with inflammatory bowel disease in a prospectively recruited population-based cohort.
    Rönnblom A; Ljunggren Ö; Karlbom U
    Scand J Gastroenterol; 2021 Nov; 56(11):1296-1303. PubMed ID: 34369245
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The problem of chronic inflammatory bowel disease.
    Watson DW
    Calif Med; 1972 Jul; 117(1):25-41. PubMed ID: 5039802
    [No Abstract]   [Full Text] [Related]  

  • 66. Cause of death in patients with inflammatory bowel disease.
    Cucino C; Sonnenberg A
    Inflamm Bowel Dis; 2001 Aug; 7(3):250-5. PubMed ID: 11515852
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of inflammatory bowel disease: an effective and concise approach.
    Hardy TG; Samson RB; Stewart WR; Hartmann RF; Fatayer WT
    Dis Colon Rectum; 1980; 23(4):244-8. PubMed ID: 6248309
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Severe Sepsis Outcomes Among Hospitalizations With Inflammatory Bowel Disease.
    Colbert JF; Schmidt EP; Faubel S; Ginde AA
    Shock; 2017 Feb; 47(2):128-131. PubMed ID: 27617672
    [TBL] [Abstract][Full Text] [Related]  

  • 69. If variety is the spice of life, we need to rethink our recipe: variation in inflammatory bowel disease practice among tertiary centers.
    Kane S
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1201-3. PubMed ID: 25638587
    [No Abstract]   [Full Text] [Related]  

  • 70. International comparison of mortality from inflammatory bowel disease in the Latin-speaking countries Venezuela, Italy, and France.
    D'Oliveira R; Mayberry JF; Newcombe RG; Rhodes J
    Digestion; 1984; 29(4):239-41. PubMed ID: 6468770
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Can we change the natural history of Crohn's disease with early immunomodulation?
    Markowitz J
    Dig Dis; 2014; 32(4):345-50. PubMed ID: 24969278
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Preventing Collateral Damage in Crohn's Disease: The Lémann Index.
    Fiorino G; Bonifacio C; Peyrin-Biroulet L; Danese S
    J Crohns Colitis; 2016 Apr; 10(4):495-500. PubMed ID: 26744441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inflammatory bowel disease course in Crohn's disease: is the natural history changing?
    Golovics PA; Mandel MD; Lovasz BD; Lakatos PL
    World J Gastroenterol; 2014 Mar; 20(12):3198-207. PubMed ID: 24696605
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of drug therapy in inflammatory bowel disease.
    Hodgson HJ
    Br J Clin Pharmacol; 1982 Aug; 14(2):159-70. PubMed ID: 7049211
    [No Abstract]   [Full Text] [Related]  

  • 75. Time to put another surgical dogma to sleep?
    Nakakura EK
    JAMA Surg; 2014 May; 149(5):466. PubMed ID: 24647825
    [No Abstract]   [Full Text] [Related]  

  • 76. Complications of excessive operative fluid administration in children receiving steroids for inflammatory bowel disease.
    Mulvihill SJ; Fonkalsrud EW
    J Pediatr Surg; 1984 Jun; 19(3):274-7. PubMed ID: 6747788
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current scenario in inflammatory bowel disease: drug development prospects.
    Chandel S; Prakash A; Medhi B
    Pharmacol Rep; 2015 Apr; 67(2):224-9. PubMed ID: 25712643
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intestinal epithelium in inflammatory bowel disease.
    Coskun M
    Front Med (Lausanne); 2014; 1():24. PubMed ID: 25593900
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inflammatory bowel diseases: Current problems and future tasks.
    Actis GC; Pellicano R; Rosina F
    World J Gastrointest Pharmacol Ther; 2014 Aug; 5(3):169-74. PubMed ID: 25133045
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lymphatic dysregulation in intestinal inflammation: new insights into inflammatory bowel disease pathomechanisms.
    Becker F; Yi P; Al-Kofahi M; Ganta VC; Morris J; Alexander JS
    Lymphology; 2014 Mar; 47(1):3-27. PubMed ID: 25109166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.